123 related articles for article (PubMed ID: 8893336)
1. Prognostic significance of molecular biological and immunohistological parameters in gastrointestinal carcinomas.
Rüschoff J; Bocker T; Vogel P; Schlegel J
Recent Results Cancer Res; 1996; 142():73-88. PubMed ID: 8893336
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.
Wang Q; Lasset C; Desseigne F; Saurin JC; Maugard C; Navarro C; Ruano E; Descos L; Trillet-Lenoir V; Bosset JF; Puisieux A
Hum Genet; 1999; 105(1-2):79-85. PubMed ID: 10480359
[TBL] [Abstract][Full Text] [Related]
4. Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.
Tannapfel A; Weinans L; Geissler F; Schütz A; Katalinic A; Köckerling F; Hauss J; Wittekind C
Dig Dis Sci; 2000 Feb; 45(2):317-24. PubMed ID: 10711445
[TBL] [Abstract][Full Text] [Related]
5. Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.
Milsmann C; Füzesi L; Heinmöller E; Krause P; Werner C; Becker H; Horstmann O
Langenbecks Arch Surg; 2008 Jan; 393(1):49-58. PubMed ID: 17876601
[TBL] [Abstract][Full Text] [Related]
6. [Disruption of mismatch repair system in human cancers].
Fukushige S; Horii A
Nihon Rinsho; 1996 Apr; 54(4):1002-7. PubMed ID: 8920664
[TBL] [Abstract][Full Text] [Related]
7. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.
Liu T; Yan H; Kuismanen S; Percesepe A; Bisgaard ML; Pedroni M; Benatti P; Kinzler KW; Vogelstein B; Ponz de Leon M; Peltomäki P; Lindblom A
Cancer Res; 2001 Nov; 61(21):7798-802. PubMed ID: 11691795
[TBL] [Abstract][Full Text] [Related]
8. A hMLH1 genomic mutation and associated novel mRNA defects in a hereditary non-polyposis colorectal cancer family.
Tanko Q; Franklin B; Lynch H; Knezetic J
Mutat Res; 2002 Jun; 503(1-2):37-42. PubMed ID: 12052501
[TBL] [Abstract][Full Text] [Related]
9. DNA mismatch repair in lymphoblastoid cells from hereditary non-polyposis colorectal cancer (HNPCC) patients is normal under conditions of rapid cell division and increased mutational load.
Tomlinson IP; Hampson R; Karran P; Bodmer WF
Mutat Res; 1997 Mar; 383(2):177-82. PubMed ID: 9088350
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic tumor markers in the gastrointestinal tract.
Seregni E; Ferrari L; Martinetti A; Bombardieri E
Semin Surg Oncol; 2001 Mar; 20(2):147-66. PubMed ID: 11398208
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
[TBL] [Abstract][Full Text] [Related]
12. Loss or somatic mutations of hMSH2 occur in hereditary nonpolyposis colorectal cancers with hMSH2 germline mutations.
Lu SL; Akiyama Y; Nagasaki H; Nomizu T; Ikeda E; Baba S; Ushio K; Iwama T; Maruyama K; Yuasa Y
Jpn J Cancer Res; 1996 Mar; 87(3):279-87. PubMed ID: 8613431
[TBL] [Abstract][Full Text] [Related]
13. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
14. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
15. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.
Lynch HT; Lemon SJ; Karr B; Franklin B; Lynch JF; Watson P; Tinley S; Lerman C; Carter C
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):987-91. PubMed ID: 9419392
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
Gologan A; Sepulveda AR
Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
[TBL] [Abstract][Full Text] [Related]
17. Are "micrometastases" of the peritoneum equivalent to distant metastases?
Kienle P; Koch M
Dig Surg; 2002; 19(6):453-8. PubMed ID: 12499736
[TBL] [Abstract][Full Text] [Related]
18. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.
Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A
Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963
[TBL] [Abstract][Full Text] [Related]
19. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.
Konishi M; Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Onda A; Okumura Y; Kishi N; Iwama T; Mori T; Koike M; Ushio K; Chiba M; Nomizu S; Konishi F; Utsunomiya J; Miyaki M
Gastroenterology; 1996 Aug; 111(2):307-17. PubMed ID: 8690195
[TBL] [Abstract][Full Text] [Related]
20. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
